APA (7th ed.) Citation

X, W., Y, Z., P, L., S, F., L, X., W, J., . . . Y, M. (2026). Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers. World journal of surgical oncology, 24(1), . https://doi.org/10.1186/s12957-026-04393-5

Chicago Style (17th ed.) Citation

X, Wang, Zha Y, Li P, Fu S, Xu L, Jiang W, Wu J, and Mao Y. "Safety and Efficacy of PD-1/PD-L1 Inhibitors Combined with Albumin-bound Paclitaxel and Fluorouracil-based Agents as Second-line Therapy in Biliary Tract Cancers." World Journal of Surgical Oncology 24, no. 1 (2026). https://doi.org/10.1186/s12957-026-04393-5.

MLA (9th ed.) Citation

X, Wang, et al. "Safety and Efficacy of PD-1/PD-L1 Inhibitors Combined with Albumin-bound Paclitaxel and Fluorouracil-based Agents as Second-line Therapy in Biliary Tract Cancers." World Journal of Surgical Oncology, vol. 24, no. 1, 2026, https://doi.org/10.1186/s12957-026-04393-5.